Searchable abstracts of presentations at key conferences in endocrinology

ea0081p164 | Pituitary and Neuroendocrinology | ECE2022

Links between posterior pituitary activity, other endocrine abnormalities and psychometric profile in anorexia nervosa: a multimodal evaluation

Galusca Bogdan , Emmanuelle Doua Singoh Sandra , Germain Natacha , Mannel Merabet , Jerome Redoute , Boutet Claire , Catherine Massoubre

Introduction: Opioid system activity was found disturbed in several reward circuit areas in restrictive anorexia nervosa (AN) patients but also surprisingly at the pituitary level. However, the potential role of this specific abnormality of pituitary in AN physiopathology remains unclear or unknown.Objectives: The first aim was to find the exact pituitary location (posterior and/or anterior) of this disturbed opioid activity and then to study the link be...

ea0077hdi1.1 | How do I. . .? 1 | SFEBES2021

Dr Claire Higham

Higham Claire

This talk will cover the currently available evidence describing the endocrine and metabolic consequences of radiotherapy treatment to the hypothalamus and pituitary. A practical approach to surveillance, diagnosis and management of these consequences in childhood and adult cancer survivors will be provided....

ea0050s1.3 | Steroids and the Skeleton | SFEBES2017

Skeletal actions of glucocorticoids – in vivo models

Wood Claire

Glucocorticoids are effective for the treatment of many chronic conditions but their use is associated with frequent and wide-ranging adverse effects including osteoporosis and growth retardation. The mechanisms that underlie the undesirable effects of GCs on skeletal development are unclear and there is no proven effective treatment to combat them. An in-vivo model that investigates the development and progression of GC-induced changes in bone is, therefore, importan...

ea0050cmw1.3 | Workshop 1: Collateral damage of cancer treatment | SFEBES2017

Bone health in cancer survivors

Higham Claire

Cancer and treatments for cancer can have a significant impact on bone health in both children and adults. There are emerging data that bone mineral density is often reduced in survivors of childhood cancers and survivors of both solid tumours and haematological malignancies in adults. Fracture rates in childhood cancer survivors have not been shown to be increased. Older adult cancer survivors, particularly those treated with aromatase inhibitors and androgen deprivation ther...

ea0050s1.3 | Steroids and the Skeleton | SFEBES2017

Skeletal actions of glucocorticoids – in vivo models

Wood Claire

Glucocorticoids are effective for the treatment of many chronic conditions but their use is associated with frequent and wide-ranging adverse effects including osteoporosis and growth retardation. The mechanisms that underlie the undesirable effects of GCs on skeletal development are unclear and there is no proven effective treatment to combat them. An in-vivo model that investigates the development and progression of GC-induced changes in bone is, therefore, importan...

ea0050cmw1.3 | Workshop 1: Collateral damage of cancer treatment | SFEBES2017

Bone health in cancer survivors

Higham Claire

Cancer and treatments for cancer can have a significant impact on bone health in both children and adults. There are emerging data that bone mineral density is often reduced in survivors of childhood cancers and survivors of both solid tumours and haematological malignancies in adults. Fracture rates in childhood cancer survivors have not been shown to be increased. Older adult cancer survivors, particularly those treated with aromatase inhibitors and androgen deprivation ther...

ea0032n4 | (1) | ECE2013

Nurse led telephone clinic: antenatal hypothyroidism

Goedhart Claire

Background: Hypothyroidism is characterised by insufficient secretion of the thyroid and its detection measured by elevated serum TSH levels.Although relatively common during pregnancy, untreated maternal hypothyroidism is associated with adverse obstetric and neonatal outcomes such as preeclampsia, placental abruption and miscarriage, or foetal neurodevelopment defects.Highlighting a nurse led specialised telephone clinic in the c...

ea0050ep106 | Thyroid | SFEBES2017

Hyperthyroidism secondary to weight loss supplements

Mitchell Kirsten , McDougall Claire

Case History: A 26 year old female patient was referred to her local endocrine clinic having presented to her GP complaining of ankle swelling. Routine biochemistry revealed a suppressed TSH (<0.05 U/l), and reduced serum levels of free T4 (2.0 pmol/l) and T3 (3.2 pmol/l). Random serum cortisol measurements were also elevated on 2 separate occasions (1266 nmol/l and 991 nmol/l). Clinical examination revealed her to be clinically euthyroid with no evidence of ...

ea0050ep106 | Thyroid | SFEBES2017

Hyperthyroidism secondary to weight loss supplements

Mitchell Kirsten , McDougall Claire

Case History: A 26 year old female patient was referred to her local endocrine clinic having presented to her GP complaining of ankle swelling. Routine biochemistry revealed a suppressed TSH (<0.05 U/l), and reduced serum levels of free T4 (2.0 pmol/l) and T3 (3.2 pmol/l). Random serum cortisol measurements were also elevated on 2 separate occasions (1266 nmol/l and 991 nmol/l). Clinical examination revealed her to be clinically euthyroid with no evidence of ...

ea0033p71 | (1) | BSPED2013

GH neurosecretory dysfunction may be associated with structural abnormalities of the hypothalamic–pituitary axis

Hughes Claire , Dattani Mehul

Introduction: GH neurosecretory dysfunction (NSD) refers to children with abnormal auxology, normal GH responses to provocative testing, but with impaired spontaneous GH secretion over 24 h, leading to low IGF1 concentrations. It is thought to be due to abnormal hypothalamic function with aberrant GHRH and somatostatin secretion leading to impaired GH secretion and subsequently suboptimal growth.Methods: We reviewed children admitted for spontaneous GH s...